Blueprint Medicines Corporation

Символ: 0HOJ.L

LSE

91.075

USD

Пазарна цена днес

  • -23.2788

    Съотношение P/E

  • -0.1299

    Коефициент PEG

  • 5.58B

    MRK Cap

  • 0.00%

    Доходност на DIV

Blueprint Medicines Corporation Структура на управлението

Информация за управлението

ИмеЗаглавие
Dr. Fouad Namouni M.D.President of Research & Development
Mr. Alexis A. Borisy A.M.Co-Founder & Director
Ms. Kathryn HavilandPresident, Chief Executive Officer & Director
Mr. Michael LandsittelChief Financial Officer
Ms. Christina RossiChief Operating Officer
Jenna CohenSenior Director & Head of Investor Relations
Ms. Tracey L. McCain Esq.Executive Vice President, Chief Legal & Compliance Officer and Secretary
Dr. Percy H. Carter M.B.A., Ph.D.Chief Scientific Officer
Ms. Ariel HurleySenior Vice President, Finance & Principal Accounting Officer
Dr. Christopher K. Murray Ph.D.Senior Vice President of Technical Operations and Chief Technical Operations & Quality Officer